Boom Or Bust: Where Does Asensus Surgical Inc (AMEX: ASXC) Stock Go From Here?

During the last session, Asensus Surgical Inc (AMEX:ASXC)’s traded shares were 1.47 million, with the beta value of the company hitting 1.44. The 52-week high for the ASXC share is $0.70, that puts it down -191.67 from that peak though still a striking 16.67% gain since the share price plummeted to a 52-week low of $0.20. The company’s market capitalization is $65.55M, and the average trade volume was 1.61 million shares over the past three months.

Asensus Surgical Inc (AMEX:ASXC) trade information

Asensus Surgical Inc (ASXC) registered a -0.82% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.82% in intraday trading to $0.24, hitting a weekly high. The stock’s 5-day price performance is -4.63%, and it has moved by 4.78% in 30 days. Based on these gigs, the overall price performance for the year is -62.92%.

Asensus Surgical Inc (ASXC) estimates and forecasts

Statistics show that Asensus Surgical Inc has outperformed its competitors in share price, compared to the industry in which it operates. Asensus Surgical Inc (ASXC) shares have gone up 5.24% during the last six months, with a year-to-date growth rate more than the industry average at 36.67% against 14.60. In the rating firms’ projections, revenue will increase 43.40% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 1.2M as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to 1.28M by the end of current fiscal year.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 39.50%. While earnings are projected to return 38.33% in 2024.

ASXC Dividends

Asensus Surgical Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Asensus Surgical Inc (AMEX:ASXC)’s Major holders